Publications
40
Citations
709
Est. group size
—
Recurring co-author estimate
Active years
17
Publishing since 2010
Typically publishes in teams of ~7 · 0% small-team papers (≤3 authors) · across 11 venues
- Predictors for T cell receptor excision circles in infants without severe combined immunodeficiency or thymic aplasia/hypoplasia
Annals of Allergy Asthma & Immunology · 2026
- O30: REKLAIM: A first in human phase Ib clinical trial of FBX-101 (AAVrh10.GALC) intravenously administered after UCBT for infantile Krabbe disease
Genetics in Medicine Open · 2024
- 154 Neurodevelopmental Outcomes (ND) in Patients with Severe Combined Immunodeficiency (SCID) Following Hematopoietic Cell Transplantation (HCT) in the Era of Newborn Screening. A PIDTC Study
Clinical Immunology · 2024
- P014: First-in-human phase 1/2 trial of intravenous FBX-101 with cord blood transplantation increases GALC, brain and motor development in infantile Krabbe
Genetics in Medicine Open · 2023
- Graft-versus-host disease is associated with skewed γδ T-cell clonality after umbilical cord blood transplantation in children with nonmalignant diseases
Cytotherapy · 2023
- Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy
Transplantation and Cellular Therapy · 2023
- First-in-human phase 1/2 trial of intravenous FBX-101 following hematopoietic stem cell transplantation increases GALC activity, supports brain development, and improves motor function in patients with infantile Krabbe disease: RESKUE clinical trial
Molecular Genetics and Metabolism · 2023
- Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders
Journal of Allergy and Clinical Immunology · 2021
- Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab
Cytotherapy · 2020
- Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity
Blood · 2020
- Safety and Efficacy of Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation to Accelerate Immune Reconstitution Prior to Thymopoiesis
Biology of Blood and Marrow Transplantation · 2019
- The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)
Journal of Allergy and Clinical Immunology · 2018
- Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation: 5% of Thawed Single Cord Blood Unit Refrozen on Day of Transplant Is Safe with Signals of Efficacy in Improving Donor Derived Immunity
Blood · 2018
- Disseminated Lichtheimia ramosa Infection After Hematopoietic Stem Cell Transplantation in a Child With Chronic Granulomatous Disease
The Pediatric Infectious Disease Journal · 2017
- Genotype, Phenotype and T Cell Counts at One Year Predict Survival and Long Term Immune Reconstitution after Transplantation in Severe Combined Immune Deficiency (SCID)—The Primary Immune Deficiency Treatment Consortium (PIDTC)
Biology of Blood and Marrow Transplantation · 2017
- Biology of Blood and Marrow Transplantation×8
- Blood×6
- Journal of Allergy and Clinical Immunology×2
- Genetics in Medicine Open×2
- Cytotherapy×2
- Rolla Abu‐Arja
Medicine · The Ohio State University
- Mark T. Vander Lugt
Medicine · University of Michigan
- Ann Friedman
Medicine · University of Michigan
- M Sykes
Medicine · University of Michigan
- John Magenau
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile